Despite having been available for more than two decades, the demand for prefilled syringes continues to grow, given the numerous benefits they offer over conventional injectable drug delivery systems
Roots Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringes Market (5th Edition), 2020-2030.”
The report features an extensive study of the current market landscape of prefilled syringes and the likely future opportunities associated with such devices, over the next 10-12 years. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed overview of the current market landscape of companies engaged in manufacturing prefilled syringes.
A detailed overview of the current market landscape of companies that are developing drugs in combination with prefilled syringes.
A detailed competitiveness analysis of the various prefilled syringes that we came across..
A list of marketed drugs / therapies and pipeline candidates that are likely to be developed in combination with prefilled syringes in the near future.
An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe manufacturers (with regard to likely collaboration opportunities for combination product development).
An analysis of the various prefilled syringe combination product-related initiatives of big pharma players.
A review of the landscape of contract fill / finish services providers that offer services for prefilled syringes, featuring a list of active (large-sized) service providers and analysis based on a number of relevant parameters.
An informative summary of various guidelines established and issued by major regulatory bodies for the approval of prefilled syringes, across different countries / geographical regions.
Brief discussions of currently available specialty syringes.